Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Massachusetts Institute of Technology, Medical Devices Deals, 2011 to YTD 2017 10
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 14
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 15
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 16
Licensing Agreements 17
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 17
Cognito Therapeutics Enters into Licensing Agreement with Massachusetts Institute of Technology 19
Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 20
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 21
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 23
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 25
Visterra Enters into Licensing Agreement with MIT for Dengue Virus Antibodies 26
Cell2B Enters into Licensing Agreement with Massachusetts Institute of Technology and Instituto Superior Tecnico 27
Enumeral Biomedical Amends Licensing Agreement with Massachusetts Institute of Technology 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 29
Columbia Labs Enters into Licensing Agreement for IVR Technology 31
Gensight Biologics Enters into Option Agreement with Massachusetts Institute of Technology 32
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 33
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 35
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 36
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 38
Pervasis Therapeutics Enters Into Licensing Agreement With Massachusetts Institute 39
Massachusetts Institute of Technology – Key Competitors 41
Massachusetts Institute of Technology – Key Employees 42
Massachusetts Institute of Technology – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 44
Government and Public Interest 44
Oct 12, 2017: New technique scours the genome for genes that combat disease 44
Sep 04, 2017: Study suggests simple way to predict preterm births 46
Jul 20, 2017: Study Predicts Heart Cells’ Response to Dwindling Oxygen 48
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 50
Jul 12, 2017: Antibiotic Nanoparticles Fight Drug-resistant Bacteria 53
Mar 20, 2017: Tethered nanoparticles make tumor cells more vulnerable 55
Feb 10, 2017: U.S. Scientists Receive Inaugural $87 Million Grand Challenge Awards To Accelerate Global Progress To Beat Cancer Sooner 57
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 58
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 60
Aug 15, 2016: New enzyme-mapping advance could help drug development 62
Jul 04, 2016: Engineers design programmable RNA vaccines 64
Jun 08, 2016: Drug candidate shrinks tumor when delivered by plant virus nanoparticle 66
May 02, 2016: New drug-delivery approach holds potential for treating obesity 68
Apr 21, 2016: Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer 70
Feb 01, 2016: Curing disease by repairing faulty genes : Massachusetts Institute of Technology 71
Jan 25, 2016: Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months 73
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 74
Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 76
Product News 78
Nov 16, 2016: Next-generation biomaterial being developed to treat bleeding 78
May 02, 2016: Massachusetts Institute of Technology: Fat-fighting nanoparticles 79
Apr 18, 2017: Long-lasting drug delivery system may help decrease the spread of malaria 81
Apr 06, 2016: Engineers develop a pill for long-term drug release 82
Feb 27, 2017: New technology offers fast peptide synthesis 84
Appendix 86
Methodology 86
About GlobalData 86
Contact Us 86
Disclaimer 86
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Key Facts 2
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Massachusetts Institute of Technology, Deals By Therapy Area, 2011 to YTD 2017 9
Massachusetts Institute of Technology, Medical Devices Deals, 2011 to YTD 2017 10
Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 14
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 15
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 16
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 17
Cognito Therapeutics Enters into Licensing Agreement with Massachusetts Institute of Technology 19
Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 20
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 21
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 23
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 25
Visterra Enters into Licensing Agreement with MIT for Dengue Virus Antibodies 26
Cell2B Enters into Licensing Agreement with Massachusetts Institute of Technology and Instituto Superior Tecnico 27
Enumeral Biomedical Amends Licensing Agreement with Massachusetts Institute of Technology 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 29
Columbia Labs Enters into Licensing Agreement for IVR Technology 31
Gensight Biologics Enters into Option Agreement with Massachusetts Institute of Technology 32
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 33
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 35
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 36
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 38
Pervasis Therapeutics Enters Into Licensing Agreement With Massachusetts Institute 39
Massachusetts Institute of Technology, Key Competitors 41
Massachusetts Institute of Technology, Key Employees 42
Massachusetts Institute of Technology, Subsidiaries 43
